Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rappoport

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
WORLD (Oakland, Calif. : 1993)|May 22, 2001
What is happening to my body?C Rappoport
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Current challenges to HIV researchG Szekeres, C Rappoport, D Abrams
HIV Medicine|February 26, 2015
Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialN Geffen, P Aagaard, G M Corbelli, et al.
HIV Medicine|April 6, 2005
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohortW M El-Sadr, C M Mullin, A Carr, et al.
HIV Medicine|February 26, 2015
Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ Grarup, C Rappoport, N W Engen, et al.
The New England Journal of Medicine|December 1, 2006
CD4+ count-guided interruption of antiretroviral treatment, W M El-Sadr, J D Lundgren, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
WORLD (Oakland, Calif. : 1993)|May 22, 2001
What is happening to my body?C Rappoport
BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation|May 22, 2001
Current challenges to HIV researchG Szekeres, C Rappoport, D Abrams
HIV Medicine|February 26, 2015
Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialN Geffen, P Aagaard, G M Corbelli, et al.
HIV Medicine|April 6, 2005
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohortW M El-Sadr, C M Mullin, A Carr, et al.
HIV Medicine|February 26, 2015
Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ Grarup, C Rappoport, N W Engen, et al.
The New England Journal of Medicine|December 1, 2006
CD4+ count-guided interruption of antiretroviral treatment, W M El-Sadr, J D Lundgren, et al.
Pageof 1